These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 12475394
1. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor. Nachtergael I, Vertongen P, Langer I, Perret J, Robberecht P, Waelbroeck M. Biochem J; 2003 Mar 15; 370(Pt 3):1003-9. PubMed ID: 12475394 [Abstract] [Full Text] [Related]
2. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition. Van Rampelbergh J, Juarranz MG, Perret J, Bondue A, Solano RM, Delporte C, De Neef P, Robberecht P, Waelbroeck M. Br J Pharmacol; 2000 Jun 15; 130(4):819-26. PubMed ID: 10864888 [Abstract] [Full Text] [Related]
3. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P. J Pharmacol Exp Ther; 2005 Aug 15; 314(2):745-52. PubMed ID: 15872042 [Abstract] [Full Text] [Related]
11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R. Mol Cell Neurosci; 2006 Feb 15; 31(2):193-209. PubMed ID: 16226889 [Abstract] [Full Text] [Related]
14. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors. Vertongen P, Langlet C, Langer I, Gaspard N, Robberecht P. Peptides; 2004 Nov 15; 25(11):1943-9. PubMed ID: 15501526 [Abstract] [Full Text] [Related]
15. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells. Fukuchi M, Sakuragawa S, Tabuchi A, Tsuda M. J Neurosci Res; 2004 Jul 01; 77(1):26-34. PubMed ID: 15197736 [Abstract] [Full Text] [Related]
16. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB, Niewiadomski P, Nowak JZ. Gen Comp Endocrinol; 2004 Jun 01; 137(2):187-95. PubMed ID: 15158130 [Abstract] [Full Text] [Related]
19. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands. Juarranz MG, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, Waelbroeck M. Mol Pharmacol; 1999 Dec 01; 56(6):1280-7. PubMed ID: 10570056 [Abstract] [Full Text] [Related]
20. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide. Nicole P, Lins L, Rouyer-Fessard C, Drouot C, Fulcrand P, Thomas A, Couvineau A, Martinez J, Brasseur R, Laburthe M. J Biol Chem; 2000 Aug 04; 275(31):24003-12. PubMed ID: 10801840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]